Bohdan Halibey
Medical Oncology · Sparta, NJNPI 1841277803
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Cornerstone Specialty Network LLC accounts for 76.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $4,519 and has fallen 99.7% since, to $14 in 2023.
Across 79 payments — averaging $57.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cornerstone Specialty Network LLC$3K
- Merck$164
- Amgen$118
- E.r. Squibb & Sons, L.L.C.$116
- Johnson & Johnson$100
- Astellas Pharma US Inc$88
- plus $480 from 15 others
Across 5 payments — averaging $4048.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$20K
What the payments were for
- Speaking & faculty fees$2,50055%
- Travel & lodging$63914%
- Food & beverage$1,42431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cornerstone Specialty Network LLC | 3 | $3,498 |
| Merck | 12 | $164 |
| Amgen | 8 | $118 |
| E.r. Squibb & Sons, L.L.C. | 9 | $116 |
| Johnson & Johnson(2 entities) | 7 | $100 |
| Astellas Pharma US Inc | 6 | $88 |
| AstraZeneca(2 entities) | 5 | $72 |
| Pfizer | 5 | $70 |
| Genentech USA, Inc. | 5 | $69 |
| Novartis | 4 | $56 |
| Gilead(2 entities) | 3 | $43 |
| Lilly USA, LLC | 2 | $28 |
| EMD Serono, Inc. | 2 | $27 |
| Stemline Therapeutics Inc. | 1 | $17 |
| Tesaro, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $13 |
| Mylan Institutional Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$4,563 in reported general payments places this provider in the 60th percentile of 112 medical oncology providers in New Jersey.
Other medical oncology in Sparta
- James McCloskeyHackensack$2.8M
- Jamie KoprivnikarHackensack$1.7M
- Andrew PecoraHackensack$1.2M
- David VesoleHackensack$726K
- Lori LeslieHackensack$665K
- Noa BiranHackensack$263K
- Robert AlterHackensack$232K
- Harry HarperHackensack$226K
- Tatyana FeldmanHackensack$193K
- David SiegelHackensack$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.